However, both immunoblotting and immunostaining analyses revealed increased CD147 protein expression accompanied by reduced HSPA12A expression in human RCC tumors compared to their normal counterparts (Figure 5A-B), indicating that HSPA12A might negatively regulate CD147 expression. The gene discussed is HSPA12A; the disease is renal cell adenocarcinoma.